The present invention provides compositions for the intranasal administrationof granisetron or a pharmaceutically acceptable salt thereof. Preferredcompositions of the invention are in the form of an aqueous solution.Optionally, the compositions of the invention comprise chitosan, a salt orderivative thereof or a salt of a derivative of chitosan. The compositions canbe used for the treatment or prevention of nausea and/or vomiting.